Sign in

CIK 0001863127

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

Tyra Biosciences, Inc.

Sign in to watch
Ticker
TYRA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
831476348
Phone
+1 619-728-4760
Business address
2656 STATE STREET, CARLSBAD, CA, 92008
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Planned sale Chief Executive Officer sold 2,000 shares at $16.13 ($32,252)
  9. 4 Planned sale Chief Operating Officer sold 4,400 shares at an average $16.07 ($70,729)
  10. 4 Open-market sale Chief Executive Officer sold 4,327 shares at an average $16.07 ($69,556)
  11. 4 Open-market sale Chief Operating Officer sold 13,581 shares at an average $16.03 ($217,763)
  12. 4 Open-market sale Chief Executive Officer sold 5,912 shares at $16.00 ($94,592)
  13. 4 Open-market sale Chief Executive Officer sold 19,236 shares at $16.00 ($307,776)
  14. 4 Open-market sale Chief Operating Officer sold 22,727 shares at $16.00 ($363,632)
  15. 4 Grant or award Chief Executive Officer acquired 1,808 shares (grant or award)
  16. 4 Grant or award Chief Medical Officer acquired 1,893 shares (grant or award)
  17. 4 Gift Chief Development Officer gave 8,442 shares (gift)
  18. 4 Open-market sale 10% owner sold 265,568 shares at an average $13.17 ($3,498,611)
  19. 4 Derivatives Options or other derivatives
  20. 3 Insider Initial Statement of Ownership

Page 7 of 11 · 203 filings